Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride
Objective. Establishment of an in vitro osteoclast induction model under nuclear factor-κB receptor activator ligand (RANKL) induction for investigating the effect of metformin hydrochloride (Met) on osteoclast differentiation. Methods. RANKL induced the differentiation of mouse bone marrow macropha...
Saved in:
| Main Authors: | Zhang Chen, Liu Zige, Yeow Sai Kiang, Chen Desheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2022/6778332 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fluoxetine inhibited RANKL-induced osteoclastic differentiation in vitro
by: Zhang Jing-wen, et al.
Published: (2024-12-01) -
"Betaone" barley water extract suppresses ovariectomy-induced osteoporosis in vivo and RANKL-induced osteoclast differentiation in vitro.
by: Yongjin Lee, et al.
Published: (2025-01-01) -
Denatonium inhibits RANKL-induced osteoclast differentiation and rescues the osteoporotic phenotype by blocking p65 signaling pathway
by: Sheunghun Lee, et al.
Published: (2024-12-01) -
Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
by: Yu-Xi Li, et al.
Published: (2020-01-01) -
Sinensetin serves as an AMPK activator to inhibit RANKL-induced osteoclastogenesis via osteoclast cytoskeleton reorganization
by: Yijie Gao, et al.
Published: (2025-07-01)